Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1971 1
1972 1
1973 1
1977 1
1978 1
1979 1
1981 3
1982 1
1983 2
1984 1
1985 4
1986 3
1987 10
1988 13
1989 5
1990 9
1991 14
1992 11
1993 7
1994 6
1995 5
1996 10
1997 4
1998 8
1999 9
2000 7
2001 10
2002 5
2003 4
2004 10
2005 8
2006 5
2007 9
2008 10
2009 13
2010 13
2011 13
2012 14
2013 11
2014 13
2015 12
2016 9
2017 7
2018 12
2019 17
2020 11
2021 13
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

337 results
Results by year
Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. Among authors: matthews dr. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
10-year follow-up of intensive glucose control in type 2 diabetes.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. Holman RR, et al. Among authors: matthews dr. N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10. N Engl J Med. 2008. PMID: 18784090 Free article. Clinical Trial.
Use and abuse of HOMA modeling.
Wallace TM, Levy JC, Matthews DR. Wallace TM, et al. Among authors: matthews dr. Diabetes Care. 2004 Jun;27(6):1487-95. doi: 10.2337/diacare.27.6.1487. Diabetes Care. 2004. PMID: 15161807 Review.
Canagliflozin and Stroke in Type 2 Diabetes Mellitus.
Zhou Z, Lindley RI, Rådholm K, Jenkins B, Watson J, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Shaw W, Oh R, Desai M, Matthews DR, Neal B. Zhou Z, et al. Among authors: matthews dr. Stroke. 2019 Feb;50(2):396-404. doi: 10.1161/STROKEAHA.118.023009. Stroke. 2019. PMID: 30591006 Free PMC article. Clinical Trial.
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.
Perkovic V, de Zeeuw D, Mahaffey KW, Fulcher G, Erondu N, Shaw W, Barrett TD, Weidner-Wells M, Deng H, Matthews DR, Neal B. Perkovic V, et al. Among authors: matthews dr. Lancet Diabetes Endocrinol. 2018 Sep;6(9):691-704. doi: 10.1016/S2213-8587(18)30141-4. Epub 2018 Jun 21. Lancet Diabetes Endocrinol. 2018. PMID: 29937267 Free article. Clinical Trial.
Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis.
Andreadis P, Karagiannis T, Malandris K, Avgerinos I, Liakos A, Manolopoulos A, Bekiari E, Matthews DR, Tsapas A. Andreadis P, et al. Among authors: matthews dr. Diabetes Obes Metab. 2018 Sep;20(9):2255-2263. doi: 10.1111/dom.13361. Epub 2018 Jun 10. Diabetes Obes Metab. 2018. PMID: 29756388
ADVANCE.
Matthews DR. Matthews DR. Diabetes Obes Metab. 2020 Apr;22 Suppl 2:3-4. doi: 10.1111/dom.14014. Diabetes Obes Metab. 2020. PMID: 32250523 No abstract available.
Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.
Tsapas A, Karagiannis T, Kakotrichi P, Avgerinos I, Mantsiou C, Tousinas G, Manolopoulos A, Liakos A, Malandris K, Matthews DR, Bekiari E. Tsapas A, et al. Among authors: matthews dr. Diabetes Obes Metab. 2021 Sep;23(9):2116-2124. doi: 10.1111/dom.14451. Epub 2021 Jun 15. Diabetes Obes Metab. 2021. PMID: 34047443
337 results